Perinatal and postnatal exposure to phthalates and early neurodevelopment at 6 months in healthy infants born at term

Laura Lucaccioni1, Lucia Palandri2,3, Erica Passini4

  • 1Pediatric Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

PubMed

Insights

Phthalate exposure in infants is widespread and linked to lower neurodevelopment scores, particularly in boys. This study highlights potential risks of these endocrine disruptors during early childhood development.

Area of Science:

  • Environmental Health
  • Developmental Pediatrics
  • Toxicology

Background:

  • Phthalates are ubiquitous plasticizers with endocrine-disrupting properties.
  • Exposure during critical windows like pregnancy and early childhood may impact neurodevelopment.

Purpose of the Study:

  • To investigate the association between urinary phthalate metabolite levels in newborns and infants and their global development at six months.
  • To assess neurodevelopment using the Griffiths Scales of Children Development (GSCD III).

Main Methods:

  • Longitudinal cohort study of 104 healthy Italian mother-infant pairs from birth to six months.
  • Urine samples collected at birth, 3, and 6 months analyzed for 7 phthalate metabolites.
  • Global child development assessed using GSCD III at six months.

Main Results:

  • Phthalate metabolites were detected in most urine samples (66-100%).
  • Negative associations were found between higher phthalate metabolite levels (DEHP, MBzP) and lower developmental scores (GSCD III) in infants and mothers.
  • Associations differed by child's sex, with negative links in boys and positive in girls.

Conclusions:

  • Widespread phthalate exposure is associated with reduced neurodevelopmental scores in infants.
  • The findings suggest sex-specific differences in phthalate's impact on child development.
  • Further research on non-regulated phthalates and their developmental effects is warranted.
Abstract